Novartis Sues Par Over Dementia Patch Generic
Novartis AG hit rival Par Pharmaceutical Inc. with a suit in Delaware federal court Thursday, accusing Par's proposed generic version of dementia treatment Exelon of infringing a patent covering the drug....To view the full article, register now.
Already a subscriber? Click here to view full article